These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 13746610

  • 1. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC, BOOTH BA.
    Biochem Pharmacol; 1960 Nov; 5():245-50. PubMed ID: 13746610
    [No Abstract] [Full Text] [Related]

  • 2. SOME FACTORS AFFECTING THE TUMOR-INHIBITORY PROPERTIES OF COMBINATIONS OF AZASERINE AND 6-CHLOROPURINE.
    SARTORELLI AC, BOOTH BA.
    Biochem Pharmacol; 1963 Aug; 12():847-53. PubMed ID: 14071542
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy of sarcoma 180 by combinations of DL-glyceraldehyde with 6-thioguanine or with azaserine and 6-chloro-purine.
    SARTORELLI AC, SCHOOLAR EJ, KRUSE PF.
    Proc Soc Exp Biol Med; 1960 Jun; 104():266-8. PubMed ID: 14441826
    [No Abstract] [Full Text] [Related]

  • 5. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC, BOOTH BA.
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract] [Full Text] [Related]

  • 6. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
    BOOTH BA, SARTORELLI AC.
    Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.
    HANSEN HJ, VANDEVOORDE JP, BENNETT KJ, GILES WG, NADLER SB.
    J Lab Clin Med; 1964 May; 63():801-18. PubMed ID: 14158063
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conversion of 6-chloropurine to its ribonucleotide by ascites tumor cells.
    Hampton A, Paterson AR.
    Biochim Biophys Acta; 1966 Jan 18; 114(1):185-7. PubMed ID: 5936954
    [No Abstract] [Full Text] [Related]

  • 12. [Influence of histidine and its metabolites on the biosynthesis of purines by Escherichia coli B. IV. Action on some cultures inhibited by azaserine].
    HEDEGAARD J, MASPERO SEGRE S, NGUYEN VAN THOAI, ROCHE J.
    C R Seances Soc Biol Fil; 1959 Jan 18; 153():767-71. PubMed ID: 14400512
    [No Abstract] [Full Text] [Related]

  • 13. [Influence of histidine and of its metabolites on the biosynthesis of purines by Escherichia coli B. V. Mode of action in cultures inhibited by azaserine].
    HEDEGAARD J, MASPERO-SEGRE S, NGUYEN VAN THOAI, ROCHE J.
    C R Seances Soc Biol Fil; 1959 Jan 18; 153():767-71. PubMed ID: 13848416
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BIOCHEMICAL EFFECTS OF DUAZOMYCIN A IN THE MOUSE PLASMA CELL NEOPLASM 70429.
    ANDERSON EP, BROCKMAN RW.
    Biochem Pharmacol; 1963 Dec 18; 12():1335-54. PubMed ID: 14096421
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histochemical study on enzymes of cancer cells in ascites.
    TAKEUCHI T, MAEDA A, TSUTSUMI I.
    Gan; 1955 Sep 18; 46(2-3):209-10. PubMed ID: 13262328
    [No Abstract] [Full Text] [Related]

  • 19. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ.
    Adv Cancer Res; 1963 Sep 18; 7():235-50. PubMed ID: 14153767
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.